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Abstract: Background and Aims: Dysfunctional myelination is one of the strongest 
hypotheses implicated in schizophrenia pathophysiology. Interestingly, myelination peaks 
during late adolescence, coinciding with the onset of schizophrenia. Lingo-1, a 
transmembrane signal-transducing molecule expressed on oligodendrocytes and neurons, is a 
potent negative regulator of oligodendrocyte differentiation, axonal growth and myelination. 
Since myelination and neuronal outgrowth disturbances lead to cognitive dysfunction, and 
considering the involvement of Lingo-1 in these processes, we have investigated the effects 
of pharmacological inhibition of Lingo-1 as a novel treatment for schizophrenia. Methods: 
Adolescent male Sprague Dawley rats (4 weeks) were injected subcutaneously with either 
saline vehicle or PCP (10 mg/kg, Sigma) for a total of 8 days. On the third day, rats 
(n=12/group) were concurrently treated for 5 days with either saline, olanzapine (Olz) (oral 
administration by cookie dough 1 mg/kg/day, 3 times/day) or anti-Lingo-1 functional 
antibody ab23631 (Abcam, UK), (intraventricular injection, with surgery for intracranial 
cannula implantation performed one week prior). Relative protein expression levels of Lingo-
1, and myelination marker myelin basic protein (MBP) were examined within the prefrontal 
cortex of the treated rats. Results: Lingo-1 levels were significantly increased in PCP treated 
rats (p=0.015) and MBP was significantly reduced in PCP treated rats (p=0.002); both were 
restored to near control levels in anti-Lingo-1/Olz treated rats (p=0.032). Restoration of MBP 
levels was most likely to have been caused by the anti-Lingo-1 treatment, as rats treated with 
PCP/Olz had similar MBP levels as PCP/Vehicle treated rats in the prefrontal cortex. 
Conclusions: This is the first study to have shown that Lingo-1 and myelination levels are 
altered following PCP treatment and that these levels are restored following treatment with a 
Lingo-1 antagonist. We suggest that Lingo-1 may be a suitable target for the development of 
new future therapeutic treatments for schizophrenia. 
